AGC to Establish New Production Site for Pharmaceutical Intermediates

AGC (Asahi Glass Co., Ltd.; Head Office: Tokyo; President & CEO: Kazuhiko Ishimura) announced that it will establish a new production site for pharmaceutical and agrochemical intermediates and active ingredients at its subsidiary, AGC Wakasa Chemicals Co., Ltd. (hereafter, "AGC Wakasa Chemicals").

AGC will invest 3.7 billion yen in the new plant scheduled to start operation around November 2012. This will approximately double the current production capacity for pharmaceutical and agrochemical intermediates and active ingredients, and contribute to the AGC Group´s aim to achieve net sales of 15 billion yen or more in this business segment in 2014.

As the elderly population grows in developed countries and the world faces food supply issues in conjunction with the worldwide population increase, demand for pharmaceuticals and agrochemicals is expected to continue growing. Hence the demand for intermediates and active ingredients used in the production of pharmaceuticals and agrochemicals is also projected to rise. The AGC Group has been making use of its strength in fluorine chemical technology in providing fluorinated compounds as well as other pharmaceutical and agrochemical intermediates and active ingredients to date, and will further reinforce the Group´s production capacity to accommodate the expected growth in demand.

The new plant profiled below will be the AGC Group´s fourth production site for pharmaceutical and agrochemical intermediates and active ingredients:

Location: Wakasa Techno Valley, Wakasa-cho, Mikatakaminaka-gun, Fukui prefecture Area: 28,400 square meters Items produced: Pharmaceutical and agrochemical intermediates and active ingredients Production facility: Total Capacity of chemical reactors: 140 cubic meters Number of employees: Approximately 20 AGC contributes to enriching people´s living through making use of the fluorine chemical technology cultivated over many years to offer distinguished products also in the area of pharmaceutical and agrochemical intermediates and active ingredients.

Read the full article below.

600450 AGC to Establish New Production Site for Pharmaceutical Intermediates glassonweb.com
Date: 10 November 2011
Source: www.us.agc.com

See more news about:

See more from these topics:

Others also read

AGC Asahi Glass announces that it has started the construction of a net zero-energy building (ZEB*1) at its Kashima Plant.
AGC and Kinestral Technologies announced the creation of three joint venture companies that will sell, distribute, and service Halio to the global market.
New Low-Iron Glass Offers Unparalleled Light Transmission and Color Optimization.
GGI, a premier glass fabricator and distributor, successfully tests for ASTM C1629 Hard-Body Impact Resistance.
Developed exclusively by AGC, Thermobel Scena is a unique window glazing featuring transparent spacers.
Visitors Can Explore Energy Saving, Decorative, and Ultra-Clear Glass Solutions.

Add new comment